CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on CLOVES syndrome, a rare genetic disorder, and aims to investigate a new drug that significantly improves patient outcomes. The goal is to understand the drug's molecular effects and expedite its designation as an orphan drug.
The Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, Scoliosis/Skeletal and Spinal (CLOVES) syndrome is a genetic disorder due to a gain of function mutation of the PIK3CA in a mosaic fashion.
This rare condition is associated with severe deformation and poor survival.
We identified a new drug able to dramatically improve the outcome of patients with this rare disease.
The purpose of the Proof of Concept grant is to better understand the molecular effect of this drug and…
UNIVERSITE PARIS CITE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
